Mary Ann Davies

Summary

Affiliation: University of Cape Town
Country: South Africa

Publications

  1. ncbi Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration
    Mary Ann Davies
    School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    Trop Med Int Health 16:1367-71. 2011
  2. ncbi Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study
    Mary Ann Davies
    Red Cross War Memorial Children s Hospital and the School of Child and Adolescent Health, University of Cape Town, Cape Town, The Republic of South Africa
    BMC Pediatr 8:34. 2008
  3. ncbi Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration
    Mary Ann Davies
    School of Public Health and Family Medicine, University of Cape Town
    S Afr Med J 99:730-7. 2009
  4. ncbi Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration
    Mary Ann Davies
    School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
    J Acquir Immune Defic Syndr 56:270-8. 2011
  5. ncbi Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children
    Tom G Connell
    Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa
    BMC Infect Dis 10:138. 2010
  6. ncbi The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis
    Leigh F Johnson
    Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa
    Pediatr Infect Dis J 31:474-80. 2012
  7. ncbi Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007
    Morna Cornell
    Centre for Infectious Disease Epidemiology and Research, University of Cape Town, South Africa
    AIDS 24:2263-70. 2010
  8. ncbi Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration
    Morna Cornell
    Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town
    S Afr Med J 99:653-60. 2009
  9. ncbi Antiretroviral treatment for children
    Brian Eley
    Red Cross War Memorial Children s Hospital, Rondebosch, Cape Town, South Africa
    S Afr Med J 96:988-93. 2006
  10. ncbi Low rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis
    Diane Gray
    Paediatric HIV Service, Groote Schuur Hospital, Cape Town, South Africa
    J Trop Pediatr 56:159-65. 2010

Detail Information

Publications15

  1. ncbi Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration
    Mary Ann Davies
    School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    Trop Med Int Health 16:1367-71. 2011
    ....
  2. ncbi Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study
    Mary Ann Davies
    Red Cross War Memorial Children s Hospital and the School of Child and Adolescent Health, University of Cape Town, Cape Town, The Republic of South Africa
    BMC Pediatr 8:34. 2008
    ..This study describes the utility of different measures of adherence in detecting lapses in infants and young children in Cape Town, South Africa...
  3. ncbi Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration
    Mary Ann Davies
    School of Public Health and Family Medicine, University of Cape Town
    S Afr Med J 99:730-7. 2009
    ..To assess paediatric antiretroviral treatment (ART) outcomes and their associations from a collaborative cohort representing 20% of the South African national treatment programme...
  4. ncbi Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration
    Mary Ann Davies
    School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
    J Acquir Immune Defic Syndr 56:270-8. 2011
    ..We evaluated the probability and determinants of virologic failure and switching in children in South Africa...
  5. ncbi Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children
    Tom G Connell
    Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa
    BMC Infect Dis 10:138. 2010
    ..The kinetics of IFN-gamma responses to Mycobacterium tuberculosis (MTB) antigens in HIV-infected children during treatment have not however been previously investigated...
  6. ncbi The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis
    Leigh F Johnson
    Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa
    Pediatr Infect Dis J 31:474-80. 2012
    ..This study aims to assess the likely impact of this change in guideline in South Africa...
  7. ncbi Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007
    Morna Cornell
    Centre for Infectious Disease Epidemiology and Research, University of Cape Town, South Africa
    AIDS 24:2263-70. 2010
    ..We describe patient outcomes [mortality, loss-to-follow-up (LTFU) and retention] over time in a network of South African ART cohorts...
  8. ncbi Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration
    Morna Cornell
    Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town
    S Afr Med J 99:653-60. 2009
    ....
  9. ncbi Antiretroviral treatment for children
    Brian Eley
    Red Cross War Memorial Children s Hospital, Rondebosch, Cape Town, South Africa
    S Afr Med J 96:988-93. 2006
    ..To describe the response of children during their first year on highly active antiretroviral therapy (HAART)...
  10. ncbi Low rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis
    Diane Gray
    Paediatric HIV Service, Groote Schuur Hospital, Cape Town, South Africa
    J Trop Pediatr 56:159-65. 2010
    ..4%) children, with no cases of fulminant hepatic failure. Severe hepatic events are uncommon in children on ART or isoniazid. There is no increased risk of hepatotoxicity with ART and concurrent isoniazid preventive therapy...
  11. ncbi Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting
    Mark P Nicol
    School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa
    Pediatrics 123:38-43. 2009
    ..TB; Oxford Immunotec, Oxford, United Kingdom) and the tuberculin skin test for the detection of tuberculosis infection in very young children being evaluated for active tuberculosis in a rural community setting...
  12. ncbi Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy
    James J Nuttall
    Paediatric Infectious Diseases Unit, Red Cross Children s Hospital, School of Child and Adolescent Health, University of Cape Town, Rondebosch, 7700, Cape Town, South Africa
    Int J Infect Dis 12:e99-105. 2008
    ..To describe the frequency, risk factors, and clinical features of bacillus Calmette-Guérin (BCG) complications in HIV-infected children treated with highly active antiretroviral therapy (HAART)...
  13. ncbi The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV
    Leigh F Johnson
    Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    J Acquir Immune Defic Syndr 59:417-25. 2012
    ....
  14. ncbi Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay
    Mary Ann Davies
    Red Cross Children s Hospital, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa
    AIDS 23:961-9. 2009
    ..To evaluate an enzyme-linked immunospot assay (ELISPOT) for the diagnosis of tuberculosis (TB) in HIV-infected children with suspected TB and to compare the performance of ELISPOT with the tuberculin skin test (TST)...
  15. ncbi Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents
    Brian Eley
    Department of Paediatrics and Child Health, Red Cross Children's Hospital and University of Cape Town
    S Afr Med J 94:643-6. 2004
    ..However, both ambulatory and inpatient facilities are required to manage children on HAART comprehensively...